Long-Term Benefit and Withdrawal Effect of Statins After Percutaneous Coronary Intervention: A Nationwide Population-Based Cohort Study

References

• Wang L, Peng P, Zhang O, et al. High-dose statin pretreatment decreases periprocedural myocardial infarction and cardiovascular events in patients undergoing elective percutaneous coronary intervention: a meta-analysis of twenty-four randomized controlled trials. PLoS One. 2014;9(12):e113352. doi:10.1371/journal.pone.0113352
   PubMed Web of Science ®Google Scholar
• Feng WH, Chu CY, Hsu PC, et al. The effects of secondary prevention after coronary revascularization in Taiwan. PLoS One. 2019;14(5):e0215811. doi:10.1371/journal.pone.0215811
   Web of Science ®Google Scholar
• Lloyd SM, Stott DJ, de Craen AJ, et al. Long-term effects of statin treatment in elderly people: extended follow-up of the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER). PLoS One. 2013;8(9):e72642. doi:10.1371/journal.pone.0072642
   Web of Science ®Google Scholar
• Stone NJ, Robinson JG, Lichtenstein AH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;63(25Pt B):2889–2934. doi:10.1016/j.jacc.2013.11.002
   PubMed Web of Science ®Google Scholar
• Lee SY, Oh SJ, Kim EJ, et al. Statin intensity and clinical outcome in patients with stable coronary artery disease and very low LDL-cholesterol. PLoS One. 2016;11(11):e0166246. doi:10.1371/journal.pone.0166246
   Web of Science ®Google Scholar
• Zhang H, Plutzky J, Skentzos S, et al. Discontinuation of statins in routine care settings: a cohort study. Ann Intern Med. 2013;158(7):526–534. doi:10.7326/0003-4819-158-7-201304020-00004
   PubMed Web of Science ®Google Scholar
• Sawano M, Kohsaka S, Abe T, et al. Patterns of statin non-prescription in patients with established coronary artery disease: a report from a contemporary multicenter Japanese PCI registry. PLoS One. 2017;12(8):e0182687. doi:10.1371/journal.pone.0182687
   Web of Science ®Google Scholar
• Alwhaibi M, Altoaimi M, AlRuthia Y, et al. Adherence to statin therapy and attainment of LDL cholesterol goal among patients with type 2 diabetes and dyslipidemia. Patient Prefer Adherence. 2019;13:2111–2118. doi:10.2147/PPA.S231873
   Web of Science ®Google Scholar
• Le Manach Y, Godet G, Coriat P, et al. The impact of postoperative discontinuation or continuation of chronic statin therapy on cardiac outcome after major vascular surgery. Anesth Analg. 2007;104(6):1326–1333, table of contents. doi:10.1213/01.ane.0000263029.72643.10
   PubMed Web of Science ®Google Scholar
• Bansilal S, Castellano JM, Garrido E, et al. Assessing the impact of medication adherence on long-term cardiovascular outcomes. J Am Coll Cardiol. 2016;68(8):789–801. doi:10.1016/j.jacc.2016.06.005
   PubMed Web of Science ®Google Scholar
• Giral P, Neumann A, Weill A, Coste J. Cardiovascular effect of discontinuing statins for primary prevention at the age of 75 years: a nationwide population-based cohort study in France. Eur Heart J. 2019;40(43):3516–3525. doi:10.1093/eurheartj/ehz458
   PubMed Web of Science ®Google Scholar
• Pineda A, Cubeddu LX. Statin rebound or withdrawal syndrome: does it exist? Curr Atheroscler Rep. 2011;13(1):23–30. doi:10.1007/s11883-010-0148-x
   Web of Science ®Google Scholar
• Heeschen C, Hamm CW, Laufs U, Bohm M, Snapinn S, White HD. Withdrawal of statins in patients with acute coronary syndromes. Circulation. 2003;107(3):e27. doi:10.1161/01.CIR.0000050552.32300.93
   Web of Science ®Google Scholar
• Heeschen C, Hamm CW, Laufs U, et al. Withdrawal of statins increases event rates in patients with acute coronary syndromes. Circulation. 2002;105(12):1446–1452. doi:10.1161/01.CIR.0000012530.68333.C8
   PubMed Web of Science ®Google Scholar
• Lee J, Lee JS, Park SH, Shin SA, Kim K. Cohort profile: the National Health Insurance Service-National Sample Cohort (NHIS-NSC), South Korea. Int J Epidemiol. 2016. doi:10.1093/ije/dyv319
   Web of Science ®Google Scholar
• Sung J, Hong KP. Descriptive Study on the Korean Status of Percutaneous Coronary Intervention Using National Health Insurance Service-National Sample Cohort (NHIS-NSC) database: focused on temporal trend. Korean Circ J. 2019;49(12):1155–1163. doi:10.4070/kcj.2019.0080
   Web of Science ®Google Scholar
• Jee SH, Jang Y, Oh DJ, et al. A coronary heart disease prediction model: the Korean Heart Study. BMJ Open. 2014;4(5):e005025. doi:10.1136/bmjopen-2014-005025
   Web of Science ®Google Scholar
• Kimm H, Yun JE, Lee SH, Jang Y, Jee SH. Validity of the diagnosis of acute myocardial infarction in Korean National Medical Health Insurance Claims Data: the Korean Heart Study (1). Korean Circ J. 2012;42(1):10–15. doi:10.4070/kcj.2012.42.1.10
   PubMed Web of Science ®Google Scholar
• Park JK, Kim KS, Kim CB, et al. The accuracy of ICD codes for cerebrovascular diseases in medical insurance claims. Korean J Prev Med. 2000;33(1):76–82.
   Google Scholar
• Park TH, Choi JC. Validation of stroke and thrombolytic therapy in Korean National Health Insurance Claim Data. J Clin Neurol. 2016;12(1):42–48. doi:10.3988/jcn.2016.12.1.42
   Web of Science ®Google Scholar
• Rim TH, Han J, Choi YS, et al. Retinal artery occlusion and the risk of stroke development: twelve-year nationwide cohort study. Stroke. 2016;47(2):376–382. doi:10.1161/STROKEAHA.115.010828
   PubMed Web of Science ®Google Scholar
• Shin JY, Roughead EE, Park BJ, Pratt NL. Cardiovascular safety of methylphenidate among children and young people with attention-deficit/hyperactivity disorder (ADHD): nationwide self controlled case series study. BMJ. 2016;353:i2550. doi:10.1136/bmj.i2550
   PubMed Web of Science ®Google Scholar
• Kim J, Lee HS, Nam CM, Heo JH. Effects of statin intensity and adherence on the long-term prognosis after acute ischemic stroke. Stroke. 2017;48(10):2723–2730. doi:10.1161/STROKEAHA.117.018140
   PubMed Web of Science ®Google Scholar
• Kang YM, Kim YJ, Park JY, Lee WJ, Jung CH. Mortality and causes of death in a national sample of type 2 diabetic patients in Korea from 2002 to 2013. Cardiovasc Diabetol. 2016;15(1):131. doi:10.1186/s12933-016-0451-0
   PubMed Web of Science ®Google Scholar
• Levine GN, Bates ER, Blankenship JC, et al. 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. J Am Coll Cardiol. 2011;58(24):e44–122. doi:10.1016/j.jacc.2011.08.007
   PubMed Web of Science ®Google Scholar
• Neumann FJ, Sousa-Uva M, Ahlsson A, et al. 2018 ESC/EACTS guidelines on myocardial revascularization. Eur Heart J. 2019;40(2):87–165.
   PubMed Web of Science ®Google Scholar
• Katzmann JL, Mahfoud F, Bohm M, Schulz M, Laufs U. Association of medication adherence and depression with the control of low-density lipoprotein cholesterol and blood pressure in patients at high cardiovascular risk. Patient Prefer Adherence. 2019;13:9–19. doi:10.2147/PPA.S182765
   PubMed Web of Science ®Google Scholar
• Maningat P, Gordon BR, Breslow JL. How do we improve patient compliance and adherence to long-term statin therapy? Curr Atheroscler Rep. 2013;15(1):291. doi:10.1007/s11883-012-0291-7
   PubMed Web of Science ®Google Scholar
• Virani SS, Woodard LD, Akeroyd JM, Ramsey DJ, Ballantyne CM, Petersen LA. Is high-intensity statin therapy associated with lower statin adherence compared with low- to moderate-intensity statin therapy? Implications of the 2013 American College of Cardiology/American Heart Association Cholesterol Management Guidelines. Clin Cardiol. 2014;37(11):653–659. doi:10.1002/clc.22343
   PubMed Web of Science ®Google Scholar
• Degli Esposti L, Saragoni S, Batacchi P, et al. Adherence to statin treatment and health outcomes in an Italian cohort of newly treated patients: results from an administrative database analysis. Clin Ther. 2012;34(1):190–199. doi:10.1016/j.clinthera.2011.12.011
   PubMed Web of Science ®Google Scholar
• Tziomalos K, Athyros VG, Mikhailidis DP. Statin discontinuation: an underestimated risk? Curr Med Res Opin. 2008;24(11):3059–3062. doi:10.1185/03007990802469102
   PubMed Web of Science ®Google Scholar
• Daskalopoulou SS, Delaney JA, Filion KB, Brophy JM, Mayo NE, Suissa S. Discontinuation of statin therapy following an acute myocardial infarction: a population-based study. Eur Heart J. 2008;29(17):2083–2091. doi:10.1093/eurheartj/ehn346
   Web of Science ®Google Scholar
• Spencer FA, Fonarow GC, Frederick PD, et al. Early withdrawal of statin therapy in patients with non-ST-segment elevation myocardial infarction: national registry of myocardial infarction. Arch Intern Med. 2004;164(19):2162–2168. doi:10.1001/archinte.164.19.2162
   Google Scholar
• Mann A, Esse TW, Serna O, Castel LD, Abughosh SM. Effectiveness of mailed letters to improve medication adherence among medicare advantage plan participants with chronic conditions. Patient Prefer Adherence. 2019;13:37–46. doi:10.2147/PPA.S185848
   Web of Science ®Google Scholar
• Armstrong SO, Little RA. Cost effectiveness of interventions to improve adherence to statin therapy in ASCVD patients in the United States. Patient Prefer Adherence. 2019;13:1375–1389. doi:10.2147/PPA.S213258
   PubMed Web of Science ®Google Scholar
• Stroes ES, Thompson PD, Corsini A, et al. Statin-associated muscle symptoms: impact on statin therapy-European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management. Eur Heart J. 2015;36(17):1012–1022. doi:10.1093/eurheartj/ehv043
   PubMed Web of Science ®Google Scholar
• Laufs U, Endres M, Custodis F, et al. Suppression of endothelial nitric oxide production after withdrawal of statin treatment is mediated by negative feedback regulation of rho GTPase gene transcription. Circulation. 2000;102(25):3104–3110. doi:10.1161/01.CIR.102.25.3104
   Web of Science ®Google Scholar
• Touyz RM, Schiffrin EL. Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells. Pharmacol Rev. 2000;52(4):639–672.
   PubMed Web of Science ®Google Scholar
• Li JJ, Li YS, Chu JM, et al. Changes of plasma inflammatory markers after withdrawal of statin therapy in patients with hyperlipidemia. Clin Chim Acta. 2006;366(1–2):269–273. doi:10.1016/j.cca.2005.10.021
   Web of Science ®Google Scholar
• Brandes RP, Beer S, Ha T, Busse R. Withdrawal of cerivastatin induces monocyte chemoattractant protein 1 and tissue factor expression in cultured vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 2003;23(10):1794–1800. doi:10.1161/01.ATV.0000092126.25380.BC
   Web of Science ®Google Scholar
• Chen J, Zhang ZG, Li Y, et al. Statins induce angiogenesis, neurogenesis, and synaptogenesis after stroke. Ann Neurol. 2003;53(6):743–751. doi:10.1002/(ISSN)1531-8249
   PubMed Web of Science ®Google Scholar